Product Information

DEXTROAMP-AMPHETAMIN 10 MG TAB is a generic product labeled by Lannett Company Inc., priced at $0.2391 per EA under NDC 00527076237. Its NADAC has been published 163 times since Jul 12, 2023.

FDA first approved this application on Jul 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

NDC

00527076237

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215565

FDA Approved

7/8/2022

TE Code

AB

On Market Since

7/8/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 5.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2391 per EA
All-time high$0.2909 (Sep 13, 2023)
All-time low$0.1975 (Nov 20, 2024)
52-week high$0.2568
52-week low$0.2329
Median price$0.2513
Average price$0.2505
Largest weekly change-26.5% (Nov 20, 2024)
Weeks tracked163
Tracking sinceJul 12, 2023

Price History

1W

+2.6%

1M

+2.6%

3M

+1.0%

6M

-1.4%

1Y

-6.9%

3Y

-13.9%

5Y

N/A

All

-5.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 10 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 10 MG TAB, manufactured by Lannett Company Inc., is $0.2391 per EA (NDC 00527076237), effective Aug 19, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 10 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has declined 5.8%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 10 MG TAB?

Since Jul 12, 2023, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has ranged from a low of $0.1975 (Nov 20, 2024) to a high of $0.2909 (Sep 13, 2023), with a median of $0.2513 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 10 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 10 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 10 MG TAB?

DEXTROAMP-AMPHETAMIN 10 MG TAB (NDC 00527076237) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.